JPS56110624A - Stimulating agent for synthesis of hepatic dna - Google Patents
Stimulating agent for synthesis of hepatic dnaInfo
- Publication number
- JPS56110624A JPS56110624A JP1313680A JP1313680A JPS56110624A JP S56110624 A JPS56110624 A JP S56110624A JP 1313680 A JP1313680 A JP 1313680A JP 1313680 A JP1313680 A JP 1313680A JP S56110624 A JPS56110624 A JP S56110624A
- Authority
- JP
- Japan
- Prior art keywords
- agent
- serum
- hepatic
- synthesis
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
PURPOSE: The titled agent, useful hepatic diseases, e.g. acute and chronic hepatitises, and containing a specific fraction obtained from blood plasma or serum of a mammal as an active constituent.
CONSTITUTION: A stimulating agent containing a fraction having a molecular weight of 1,000 or less and an Rf value of 0.25W0.55 measured by the thin layer chromatography (developing solvent n-butanol:acetic acid:water=12:3:5V/V) obtained from a blood plasma or serum of a mammal as an active constituent. The physical properties of the purified blood serum factor are as follows; Cololess and soluble in water, relatively slightly soluble in methanol and other organic solvents. The aqueous solution thereof will not show an absorption maximum at wavelengths of 260nm and 280nm usually. The agent has a stimulating action on the synthesis of hepatic DNA and therefore useful as a drug for accelerating the regeneration or new growth of parenchymatous cells on reduction in the number of function of the cells in the lever due to hepatic diseases, e.g. acute or chronic hepatitis, or drug poisoning. The agent is administered orally or parenterally.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1313680A JPS56110624A (en) | 1980-02-06 | 1980-02-06 | Stimulating agent for synthesis of hepatic dna |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1313680A JPS56110624A (en) | 1980-02-06 | 1980-02-06 | Stimulating agent for synthesis of hepatic dna |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS56110624A true JPS56110624A (en) | 1981-09-01 |
JPH0316326B2 JPH0316326B2 (en) | 1991-03-05 |
Family
ID=11824736
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1313680A Granted JPS56110624A (en) | 1980-02-06 | 1980-02-06 | Stimulating agent for synthesis of hepatic dna |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS56110624A (en) |
-
1980
- 1980-02-06 JP JP1313680A patent/JPS56110624A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH0316326B2 (en) | 1991-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Whittaker et al. | The separation of esters of choline by filter-paper chromatography | |
JPS56139104A (en) | Manufacture of selectively permeable membrane | |
JPS56100714A (en) | Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane | |
Svanborg et al. | Metabolism of prostaglandin F2α in the rabbit | |
JPS56110624A (en) | Stimulating agent for synthesis of hepatic dna | |
Gupta et al. | Antiinflammatory activity of some active principles of Lawsonia inermis leaves | |
JP2732259B2 (en) | New aconitine compounds and analgesic / anti-inflammatory agents | |
Welch et al. | Effect of 3-methylcholanthrene pretreatment on the bioavailability of phenacetin in the rat. | |
Licht et al. | Progress in isolation and purification of an inhibitor of sodium transport obtained from dog urine | |
CN111732619B (en) | Iridoid glycoside compound and preparation method and application thereof | |
Sekas et al. | The isolation of a low molecular weight inhibitor of [3H] TdR incorporation into hepatic DNA | |
NAITO et al. | Trimetazidine in blood, bile, organs and urine | |
JPS5533456A (en) | Separation of ginseng saponin | |
CA2382697A1 (en) | Method for encapsulating active substances by coacervation of polymers in non-chlorinated organic solvent | |
Dicuollo et al. | The Metabolism of 3-[(5-methyl-5H-as-triazino [5, 6-b]-indol-3-yl) amino]-1-propanol (SK & F 21687): A Potent Antiviral | |
KAKEMI et al. | Mechanism of drug absorption from micellar solution. I. Absorption of solubilized vitamin A from the rat intestine | |
Chien-Chin et al. | Absence of metabolite in the disappearance of nitroglycerin following incubation with red blood cells | |
US3108106A (en) | Narcqtine camphosulfonate | |
JPS5620597A (en) | Novel physiologically active substance | |
JPS53130602A (en) | New antibiotic aculeacin aalpha and its preparation | |
SU583608A1 (en) | Oximes of n-(3,4,5-trimethoxybenzoyl)-substituted-n-aminoalkylphenylketones possessing neuroleptic activity | |
JPS5432597A (en) | Purification of high molecular weight alkylene oxide polymer | |
CA2614775A1 (en) | Compositions from buckwheat for management of diabetes | |
Fromm et al. | Redistribution of methionine and cystine during experimental wound healing | |
SAITO et al. | Isolation of an active glucoside in bracken fern, Pteridium aquilinum |